Number of the records: 1  

Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study

  1. SYS0558392
    005
      
    20240103230732.0
    014
      
    $a 85132113090 $2 SCOPUS
    014
      
    $a 35693010 $2 PUBMED
    014
      
    $a 000808251100001 $2 WOS
    017
    70
    $a 10.3389/fneur.2022.874121 $2 DOI
    101
    0-
    $a eng
    102
      
    $a CH
    200
    1-
    $a Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study
    215
      
    $a 8 s.
    463
    -1
    $1 001 cav_un_epca*0460955 $1 011 $a 1664-2295 $e 1664-2295 $1 200 1 $a Frontiers in Neurology $v Roč. 13, May 26 (2022) $1 210 $c Frontiers Media
    608
      
    $a Article
    610
      
    $a multiple sclerosis
    610
      
    $a CSF
    610
      
    $a metabolomics
    610
      
    $a biomarker
    610
      
    $a fatty acids
    610
      
    $a amino acids
    610
      
    $a arginine
    700
    -1
    $3 cav_un_auth*0432334 $a Židó $b M. $y CZ
    701
    -1
    $3 cav_un_auth*0432335 $a Kačer $b D. $y CZ
    701
    -1
    $3 cav_un_auth*0107799 $a Valeš $b Karel $p FGU-C $i Neurofyziologie paměti $j Laboratory of Neurophysiology of the Memory $T Fyziologický ústav AV ČR, v. v. i.
    701
    -1
    $3 cav_un_auth*0018658 $a Svobodová $b Z. $y CZ
    701
    -1
    $3 cav_un_auth*0244798 $a Zimová $b D. $y CZ
    701
    -1
    $3 cav_un_auth*0305449 $a Štětkářová $b I. $y CZ
    856
      
    $u https://doi.org/10.3389/fneur.2022.874121 $9 RIV
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.